US › Healthcare

Collplant Biotechnologies Ltd (CLGN)

US · Healthcare · Biotechnology

$3.62-1.49%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$108,000

Revenue YoY

-39.7%

Net profit

$-2.7M

EPS

$-1.89

EPS estimate

$-2.40

Net margin

-2,524.1%

EPS came in at -1.89 against a street estimate of -2.40 — a beat of 21.3%.

Key statistics

Market cap

$7.0M

Forward P/E

80.0

P/B

1.56

Book value

$2.04

EPS (TTM)

$-8.78

52-week high

$26.80

52-week low

$2.64

50-day MA

$3.54

200-day MA

$5.77

Beta

0.76

Analyst view

with an average price target of $11.12.

Shareholding

Insiders

33.56%

Institutions

9.93%

Largest institutional holders

Fund	Stake
Parallel Advisors, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Collplant Biotechnologies Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.